<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-P062N4TZ</identifier><date>2013</date><creator>Jurič, Damijana Mojca</creator><creator>Žiberna, Lovro</creator><relation>documents/doc/P/URN_NBN_SI_doc-P062N4TZ_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-P062N4TZ_001.txt</relation><format format_type="issue">2</format><format format_type="volume">52</format><format format_type="type">article</format><format format_type="extent">str. 255-270</format><identifier identifier_type="ISSN">0025-8121</identifier><identifier identifier_type="COBISSID">30647769</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-P062N4TZ</identifier><language>slv</language><publisher>Medicinski razgledi</publisher><source>Medicinski razgledi</source><rights>InC</rights><subject language_type_id="slv">histamin</subject><subject language_type_id="eng">histamine</subject><subject language_type_id="eng">histamine receptor type 3</subject><subject language_type_id="slv">histaminski receptor tipa 3</subject><subject language_type_id="eng">intracellular signaling</subject><subject language_type_id="slv">nevrofarmakologija</subject><subject language_type_id="slv">osrednje živčevje</subject><title>Histamine receptor type 3 - from gene to drug target</title><title>Histaminski receptor tipa 3 - od gena do terapevtske tarče</title></Record>